United Therapeutics Corporation‘s (UTHR) share price has entered into oversold territory with a stochastic value of 14.220. The Zacks Consensus Estimate on the company’s earnings for December 2011 increased by 67 cents over the past month to $3.48 per share. United Therapeutics Corporation is a Zacks #1 Rank (“Strong Buy”) company.

Zacks Investment Research